Delivery Order SPE2DB20D2104-SPE2DB24FS11P
Award Date 1/18/24
Potential Completion Date 1/19/24
Potential Value $4.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of CYCLOSPORINE 0.05% EYE EMULS 60S to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $20,470.34 and an ultimate completion date of October 24, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award has a ceiling value of $1,460.42 and an ultimate completion date of January 29, 2025. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,073.53 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 12, 2023, with a completion date of September 13, 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical. This single-award IDC...
- This federal contract award is for the delivery of Cyclosporine 0.05% Eye Emulsion to the Defense Logistics Agency (DLA). The contract, valued at $1,175.64, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which was previously awarded to Cencora, Inc. and runs through December 2025. This IDC serves as the primary...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company. The contract has a ceiling value of $29,174.58 and is a Firm Fixed Price Delivery Order that runs through September 19, 2023. The award was made without any set-aside designation, indicating full and open competition....
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA), a component of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that holds several large Indefinite Delivery Contracts (IDCs) with federal agencies, including a single-award IDC with DLA Troop Support Medical valued up to $999,999,999.00 through 2025. This specific delivery order is valued at $11,859.56 and has...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a firm-fixed-price delivery order. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $9,057.01. The contract has an ultimate completion date of October 8, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The award has a ceiling value of $1,276.31 and is a Firm Fixed Price Delivery Order contract with a completion date of May 18, 2023. The contract is not designated as a set-aside. Amerisourcebergen...
- This federal contract award is for the delivery of CYCLOSPORINE 0.05% EYE EMULS 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $4,291.55, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the...
- This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical, a major medical supply chain organization within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $1,100.61 with a firm fixed price, and the ultimate...